News – Page 342 – Endpoints News

One-fifth of late-stage cancer trials changed primary endpoints after trial start, JAMA Network Open study says

3 years ago

Government-backed pilots investigate how tech can better secure the drug supply chain

3 years ago

FDA plans to only issue pediatric exclusivity for new studies — not just those required under PREA

3 years ago

Americans may not understand survival nuances in cancer brand commercials, FDA research finds

3 years ago

Novo Nordisk says oral version of Wegovy also works at reducing weight in a PhIII study

3 years ago

Exclusive: Sanofi's CEO Paul Hudson talks pipeline, M&A, insulin hearings and Dupixent

3 years ago

Krystal Biotech raises $160M via PIPE on heels of FDA approval for gene therapy

3 years ago

As it awaits key readout, Hepion boosts confidence in NASH drug hopeful via shorter study

3 years ago

Chasing the KRAS field, Quanta Therapeutics bags $50M for two 2024 clinical trials

3 years ago

Rain Oncology's stock dives after tumor treatment fails a PhIII trial

3 years ago

Emboldened by Dupixent COPD win, Sanofi execs pitch leading immunology's next era

3 years ago

Novartis beefs up gene therapy pipeline, spending $87.5M on an Avrobio therapy

3 years ago

Ironwood to buy VectivBio in $1B all-cash deal to expand rare gastrointestinal pipeline

3 years ago

Oculis says its eye drops passed an early PhIII test. Researchers have to repeat it to win approval

3 years ago

Alnylam updates its pitch for expanded Onpattro label with 18-month PhIII data

3 years ago

Alexion touts early 'proof-of-concept' data for Neurimmune antibody in ATTR cardiomyopathy

3 years ago

FTC’s M&A crackdown; NASH drug gets thumbs down; FDA OKs topical gene therapy; Company exits frustrate rare disease ...

3 years ago

Updated: In another blow for NASH, FDA adcomm opposes accelerated approval of Intercept drug

3 years ago

First-of-its-kind gene therapy approved for healing wounds in “butterfly children”

3 years ago

CureVac seeks to accelerate vaccine infringement case against Pfizer and BioNTech

3 years ago

Lung association calls for more Black Americans to join clinical trials in pharma-backed effort

3 years ago

Moderna to purchase and invest more than $320M in MA biomanufacturing site

3 years ago

Eli Lilly renews Twitter activity with a new handle and 'limited' advertising and posting

3 years ago

AbbVie, Genmab land FDA OK for CD3xCD20 bispecific, catching up with Roche

3 years ago

First page Previous page 339 340 341342343 344 345 Next page Last page